{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:52:34Z","timestamp":1790200354238,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bcp.2026.117718","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T23:11:45Z","timestamp":1768691505000},"page":"117718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Entinostat suppresses hepatocellular carcinoma metastasis by upregulating AZGP1 through histone acetylation"],"prefix":"10.1016","volume":"246","author":[{"given":"Weiguo","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodie","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5876-0860","authenticated-orcid":false,"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.117718_b0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"J. Clin."},{"key":"10.1016\/j.bcp.2026.117718_b0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3350\/cmh.2020.0016","article-title":"Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients","volume":"26","author":"Kim","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.bcp.2026.117718_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081582","article-title":"Hepatocellular Carcinoma: Current Drug Therapeutic Status, advances and challenges","volume":"16","author":"Zheng","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.117718_b0020","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.117718_b0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-016-0545-z","article-title":"Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis","volume":"15","author":"Jiang","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.117718_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116566","article-title":"Re-exploration of immunotherapy targeting EMT of hepatocellular carcinoma: Starting from the NF-\u03baB pathway","volume":"174","author":"Wang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117718_b0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41419-024-06711-9","article-title":"SOAT1 regulates cholesterol metabolism to induce EMT in hepatocellular carcinoma","volume":"15","author":"Fu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117718_b0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13148-025-01838-8","article-title":"Novel histone modifications and liver cancer: emerging frontiers in epigenetic regulation","volume":"17","author":"Wang","year":"2025","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bcp.2026.117718_b0045","article-title":"Histone modifications Represent a Key Epigenetic Feature of Epithelial-to-Mesenchyme transition in Pancreatic Cancer","volume":"24","author":"Xu","year":"2023","journal-title":"Int. J.Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117718_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052778","article-title":"Prominent Role of Histone modifications in the Regulation of Tumor Metastasis","volume":"22","author":"Markouli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117718_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/cells14171337","article-title":"Epigenetic Regulation through Histone Deacetylation: Implications and Therapeutic potential in Hepatocellular Carcinoma","volume":"14","author":"Sadia","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.117718_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2020.100167","article-title":"Epigenetics in hepatocellular carcinoma development and therapy: the tip of the iceberg","volume":"2","author":"Fern\u00e1ndez-Barrena","year":"2020","journal-title":"JHEP Reports"},{"key":"10.1016\/j.bcp.2026.117718_b0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ebiom.2017.04.014","article-title":"Prognostic Biomarker Identification through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties","volume":"19","author":"Cai","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcp.2026.117718_b0070","first-page":"657","article-title":"HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Chemotaxis and Recruiting of Immune Cells, Cancer","volume":"11","author":"Li","year":"2023","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bcp.2026.117718_b0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00109-025-02532-1","article-title":"Mechanism and application of HDAC inhibitors in the treatment of hepatocellular carcinoma","volume":"103","author":"Hao","year":"2025","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bcp.2026.117718_b0080","first-page":"47","article-title":"Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents","volume":"7","author":"Ververis","year":"2013","journal-title":"Biologics"},{"key":"10.1016\/j.bcp.2026.117718_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1170207","article-title":"HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma","volume":"14","author":"Shen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.117718_b0090","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1158\/1078-0432.CCR-07-1461","article-title":"A phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in patients with Refractory Solid Tumors and Lymphomas","volume":"14","author":"Gore","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117718_b0095","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.apsb.2023.02.001","article-title":"Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for chinese patients with hormone receptor-positive advanced breast cancer: a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial","volume":"13","author":"Xu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.117718_b0100","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.7150\/ijbs.72982","article-title":"Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways","volume":"18","author":"Yang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2026.117718_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109573","article-title":"The multi-kinase inhibitor lenvatinib interacts with the HDAC inhibitor entinostat to kill liver cancer cells","volume":"70","author":"Roberts","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bcp.2026.117718_b0110","first-page":"1991","article-title":"Combined inhibition of sonic Hedgehog signaling and histone deacetylase is an effective treatment for liver cancer","volume":"41","author":"Li","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2026.117718_b0115","doi-asserted-by":"crossref","first-page":"29540","DOI":"10.1074\/jbc.M111.263111","article-title":"Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cells","volume":"286","author":"Lin","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.117718_b0120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bcp.2026.117718_b0125","article-title":"CHML promotes liver cancer metastasis by facilitating Rab14 recycle","volume":"10","author":"Chen","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.117718_b0130","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cmet.2019.01.002","article-title":"Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by beta-Catenin Mutations","volume":"29","author":"Adebayo Michael","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.117718_b0135","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.28975","article-title":"Targeting beta-catenin in hepatocellular cancers induced by coexpression of mutant beta-catenin and K-Ras in mice","volume":"65","author":"Tao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2026.117718_b0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nprot.2006.27","article-title":"Protocol for the fast chromatin immunoprecipitation (ChIP) method","volume":"1","author":"Nelson","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bcp.2026.117718_b0145","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nmeth.3542","article-title":"ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors","volume":"12","author":"Schmidl","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bcp.2026.117718_b0150","first-page":"207","article-title":"Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN\/Akt and CD44s pathways in hepatocellular carcinoma","volume":"38","author":"Tian","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2026.117718_b0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.canlet.2016.02.025","article-title":"AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGF\u03b21-ERK2 pathways","volume":"374","author":"Xu","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.117718_b0160","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41419-023-06092-5","article-title":"AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-\u03b21\/Smad3 pathway","volume":"14","author":"Deng","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117718_b0165","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18104","article-title":"Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25","volume":"28","author":"Yun","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2026.117718_b0170","doi-asserted-by":"crossref","unstructured":"M. Yuan, X. Zhang, F. Yue, F. Zhang, S. Jiang, X. Zhou, J. Lv, Z. Zhang, Y. Sun, Z. Chen, H. Wu, X. Liu, X. Yu, B. Wei, K. Jiang, F. Lin, Y. Zuo, S. Ren, CircNOLC1 Promotes Colorectal Cancer Liver Metastasis by Interacting with AZGP1 and Sponging miR-212-5p to Regulate Reprogramming of the Oxidative Pentose Phosphate Pathway, Adv Sci (Weinh) (2023) e2205229. 10.1002\/advs.202205229.","DOI":"10.1002\/advs.202205229"},{"key":"10.1016\/j.bcp.2026.117718_b0175","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1158\/2767-9764.CRC-24-0218","article-title":"Zinc-alpha-2-glycoprotein Secreted by Triple-negative Breast Cancer Promotes Peritumoral Fibrosis","volume":"4","author":"Verma","year":"2024","journal-title":"Cancer Res. Commun."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:29:16Z","timestamp":1778056156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"alternative-id":["S0006295226000493"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117718","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Entinostat suppresses hepatocellular carcinoma metastasis by upregulating AZGP1 through histone acetylation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117718"}}